Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Colchicine on Vascular Inflammation as Assessed With Position Emission Tomography (PET) Imaging in Patients With Atherosclerotic Vascular Disease (COLPET)
NCT02162303 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Colchicine on Vascular Inflammation as Assessed With Position Emission Tomography (PET) Imaging in Patients With Atherosclerotic Vascular Disease (COLPET)
- Lead sponsor
- Montreal Heart Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2014
- Completion date
- January 31, 2016
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atherosclerotic vascular disease